  |
 | Up a level |
Heigener, D. and Gottfried, M. and Bennouna, J. and Bondarenko, I. and Douillard, J-Y. and Krzakowski, M. and Mellemgaard, A. and Novello, S. and Orlov, S. and Summers, Y.J. and von Pawel, J. and Hocke, J. and Kaiser, R. and Reck, M. (2016) Efficacy and safety of nintedanib (NIN)/docetaxel (DOC) in patients with lung adenocarcinoma: Further analyses from the LUME-Lung 1 study. Annals of Oncology, 27 (supp_6). 1276P-1276P. ISSN 0923-7534 (Print), 1569-8041 (Electronic)
Spigel, D.R. and Bondarenko, I. and Losonczy, G. and Mezger, J. and Kalofonos, H. and Reck, M. and Palmero, R. and Jang, T. and Natale, R. and Sanborn, R.E. and Lai, J. and Kallinteris, N. and Tang, M. and Shan, J. and Gerber, D. (2016) Top-line results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/iv non-squamous non-small cell lung cancer. Annals of Oncology, Vol.27 (supp_6). P.- LBA45. ISSN 0923-7534 (Print), 1569-8041 (Electronic)
